AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Informed consent obtained before any trial-related activities.
✓. At least 18 years of age (inclusive)
✓. Confirmed diagnosis of psoriatic disease with signs of nail psoriasis on at least 2 digits
✓. Minimum nail involvement as assessed by treating physician (N-NAIL score of ≥ 2 for at least two individual nails)
Exclusion criteria
✕. Insufficient knowledge of written and spoken Danish.
✕. Pregnant and lactating women and women who intend to become pregnant during the trial
✕. Pre-existing clinical manifestations of long-term side effects of corticosteroid use including but not limited to skin atrophy or telangiectasias on fingers
✕. Presence of any skin condition or coloration (marked suntan, hyperpigmentation, smoking-induced staining, tattoos or body art) that would interfere with the evaluation of the clinical response in the test sites or assessment
✕
What they're measuring
1
Efficacy of topical delivery of Enstilar® with and without laser pre-treatment to improve nail psoriasis
. Any non-psoriatic disease activity within test areas
✕. Significant history or current evidence of chronic infectious disease, systemic disorders, or organ dysfunction where the use of Enstilar is contraindicated.
✕. Known predisposition for hypertrophic scar formation.
✕. Known allergy to any of the components of Enstilar®.